Key Findings
The study established the feasibility of intrasplenic cell transplantation via the splenic artery in an operational immunodeficient pig (OIDP) model. Following the transplantation of human-induced pluripotent stem cell-derived hepatocyte-like cells (iPSC-HLCs), human albumin was detected in pig serum 2 weeks post-transplantation. Histological analysis at 4 weeks identified cell colonies positive for human albumin and vimentin. Additionally, transplantation of quantum-dot-labeled human induced tissue progenitor cell-derived islets (iTPC-derived islets) resulted in the detection of human C-peptide in serum after a glucose tolerance test, with histological confirmation of insulin-producing cells in the spleen.
Technical Details
The OIDP model involved thymectomy and the administration of tacrolimus, mycophenolate mofetil, and prednisolone via a gastric tube. To prevent rejection without removing the organ, splenic immune cells were inactivated by perfusing mitomycin C through a temporal extracorporeal circuit that isolated the spleen from systemic circulation. This circuit allowed for preconditioning before the cells were delivered via the splenic artery and vein. The study utilized adult microminiature pigs (27- to 29-mo-old, 20–24 kg) for iPSC-HLC transplantation and domestic piglets (5-wk-old, approximately 10 kg) for iTPC-derived islet transplantation.
Background and Context
While intrahepatic transplantation (such as the Edmonton protocol) has produced favorable outcomes for pancreatic islets, researchers sought an alternative ectopic site. The spleen was selected due to its sinusoidal vascular structure, which mimics that of the liver. Unlike the liver, the spleen typically remains normal in patients with diabetes and liver diseases. Furthermore, because the spleen is not a life-supporting organ, transplanted cells can be surgically removed if tumors form.
Significance and Outlook
This research provides a preclinical proof-of-concept for the use of the spleen as a site for progenitor-derived cell therapy. By utilizing a vascular approach that closely mimics clinical procedures, the study suggests the spleen is a viable alternative for the transplantation of hepatocytes and islets.
Source: https://doi.org/10.1097/txd.0000000000002025
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime



